6:18 PM
 | 
Jan 02, 2013
 |  BC Extra  |  Company News

NPS sets Gattex price

NPS Pharmaceuticals Inc. (NASDAQ:NPSP) said it set the annual list price for short bowel syndrome (SBS) drug Gattex teduglutide at $295,000. The company, which plans to launch the Orphan drug in February, said...

Read the full 155 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >